# US 2016/0354353 A9 · Trivalent chromium compounds, compositions and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354353 A9
- Document ID: US20160354353A9
- Status: Published application
- Kind: A9
- Application number: 14/793,657
- Filed: 2015-07-07
- Published: 2016-12-08
- Earliest claimed: 2006-04-12
- Assignees: Interhealth Nutraceuticals, Inc.
- Applicants: Interhealth Nutraceuticals, Inc.
- Inventors: Xiaoming X. Chien; Debasis Bagchi
- Web page: https://patentgrep.com/patent/US20160354353A9

## CPC

- A61K 31/4406: only substituted in position 3, e.g. zimeldine (nicotinic acid A61K31/455)
- A61K 31/28: Compounds containing heavy metals
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/22: Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A61K 36/38: Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
- A61K 36/49: Fagaceae (Beech family), e.g. oak or chestnut
- A61K 36/54: Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- C07C 57/44: Cinnamic acid
- C07C 59/285: Polyhydroxy dicarboxylic acids having five or more carbon atoms, e.g. saccharic acids
- C07C 65/03: monocyclic and having all hydroxy or O-metal groups bound to the ring
- C07C 229/76: Metal complexes of amino carboxylic acids
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present invention provides chromium compounds, specifically chromium dinicocysteinate, which possess the ability to improve insulin sensitization, glucose tolerance, bioavailability, efficacy, and safety, and methods for their use.

## Claims

### Claim 1

An isolated and purified complex of trivalent chromium dinicocysteinate.

### Claim 2 (depends on 1)

The isolated and purified complex of claim 1, which is water-soluble and heat stable.

### Claim 3 (depends on 1)

A composition comprising the isolated and purified complex of claim 1.

### Claim 4 (depends on 3)

The composition of claim 3 further comprising a pharmaceutically acceptable oral, topical, or intravenous carrier or a food or beverage safe carrier.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the composition is in the form of a pill, a tablet, a capsule, a powder, a lozenge, a gum, a liquid, a solution, a dietary supplement, a food, a beverage, or a topical composition.

### Claim 6

A method for treating or preventing diabetes, the method comprising administering a biologically effective amount of a composition comprising an isolated and purified complex of trivalent chromium dinicocysteinate.

### Claim 7 (depends on 6)

The method of claim 6, wherein the biologically effective amount increases vitamin C levels.

### Claim 8 (depends on 6)

The method of claim 6, wherein the biologically effective amount comprises about 10 μg to about 1000 μg of elemental chromium.

### Claim 9 (depends on 6)

The method of claim 6, wherein the composition is administered daily.

### Claim 10 (depends on 6)

The method of claim 6, wherein the biologically effective amount comprises about 400 μg of elemental chromium.

### Claim 11 (depends on 6)

The method of claim 6, wherein the subject is a mammal.

### Claim 12 (depends on 11)

The method of claim 11, wherein the mammal is human.

### Claim 13 (depends on 11)

The method of claim 11, wherein the mammal is a swine.

### Claim 14 (depends on 6)

The method of claim 6, wherein the subject is avian.

### Claim 15

A method for treating symptoms associated with diabetes or with the onset of diabetes, the method comprising administering a biologically effective amount of a composition comprising an isolated and purified complex of trivalent chromium dinicocysteinate to a subject suffering from symptoms associated with diabetes or with the onset of diabetes.

### Claim 16 (depends on 15)

The method of claim 15, wherein symptoms associated with diabetes or with the onset of diabetes are treated by lowering the blood levels of one or more of fasting glucose, glycosylated hemoglobin, monocyte chemotactic protein-1, intracellular adhesion molecule, and red blood cell lipid peroxidase.

### Claim 17 (depends on 15)

The method of claim 15, wherein symptoms associated with diabetes or with the onset of diabetes are treated by increasing the blood levels of one or both of vitamin C and adiponectin.

### Claim 18

A method for treating symptoms associated with inflammation, the method comprising administering a biologically effective amount of a composition comprising trivalent chromium dinicocysteinate to a subject suffering from inflammation.

### Claim 19 (depends on 18)

The method of claim 18, wherein symptoms are associated with atherosclerosis.

### Claim 20

A method for treating symptoms associated with cardiovascular disease, the method comprising administering a biologically effective amount of a composition comprising trivalent chromium dinicocysteinate to a subject suffering from symptoms associated with cardiovascular disease.

### Claim 21 (depends on 20)

The method of claim 20, wherein symptoms associated with cardiovascular disease are treated by lowering elevated LDL cholesterol, VLDL cholesterol, triglycerides, C-reactive protein, blood pressure and/or vascular inflammation levels, and/or increasing HDL cholesterol levels.

### Claim 22

A method for treating symptoms associated with obesity or overweight individuals, the method comprising administering a biologically effective amount of a composition comprising trivalent chromium dinicocysteinate to a subject suffering from symptoms associated with obesity or overweight individuals.

### Claim 23 (depends on 22)

The method of claim 22, wherein symptoms associated with obesity or overweight individuals are treated by lowering body weight, body fat and/or body mass index, and/or increasing lean body mass.
